Treatment Strategy for Post-hepatectomy Recurrent Hepatocellular Carcinoma Within the Milan Criteria: Repeat Resection, Local Ablative Therapy or Transarterial Chemoembolization?-Reference-Cited by-同舟云学术

Treatment Strategy for Post-hepatectomy Recurrent Hepatocellular Carcinoma Within the Milan Criteria: Repeat Resection, Local Ablative Therapy or Transarterial Chemoembolization?

Published:2022-02-26 Issue:S2 Volume:84 Page:384-389
ISSN:0972-2068
Container-title:Indian Journal of Surgery
language:en
Short-container-title:Indian J Surg

Author:

Li Jing,Yang Xiaoliang,Huang Liang,Zhu Xingwu,Qiu Maixuan,Yan Jianjun,Yan Yiqun,Wei Shaohua^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

https://link.springer.com/content/pdf/10.1007/s12262-022-03343-1.pdf

Reference23 articles.

1. Zhong JH, Ke Y, Gong WF et al (2014) Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma. Ann Surg 260:329–340

2. Chan DL, Alzahrani NA, Morris DL et al (2014) Systematic review of efficacy and outcomes of salvage liver transplantation after primary hepatic resection for hepatocellular carcinoma. J Gastroenterol Hepatol 29:31–41

3. Guo Y, Tan EK, Krishnamoorthy TL et al (2019) Outcomes of salvage liver transplant for recurrent hepatocellular carcinoma: a comparison with primary liver transplant. Ann Hepatobiliary Pancreat Surg 23:1–7

4. Hu Z, Wang W, Li Z et al (2012) Recipient outcomes of salvage liver transplantation versus primary liver transplantation: a systematic review and meta-analysis. Liver Transpl 18:1316–1323

5. Lim C, Shinkawa H, Hasegawa K et al (2017) Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: an intent-to-treat analysis. Liver Transpl 23:1553–1563

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Function of the Long Noncoding RNAs in Hepatocellular Carcinoma: Classification, Molecular Mechanisms, and Significant Therapeutic Potentials;Bioengineering;2022-08-21